INT232153

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.05
First Reported 2007
Last Reported 2007
Negated 1
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.07
Pain Relevance 0.35

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

signal transduction (Cd34) extracellular region (Cd34) cell motility (Cd34)
cell adhesion (Cd34) plasma membrane (Cd34) transcription factor binding (Cd34)
Cd34 (Rattus norvegicus)
Pain Link Frequency Relevance Heat
dexamethasone 40 92.48 High High
peripheral neuropathy 6 5.00 Very Low Very Low Very Low
aspirin 3 5.00 Very Low Very Low Very Low
Inflammation 1 5.00 Very Low Very Low Very Low
vincristine 1 5.00 Very Low Very Low Very Low
Arachnoiditis 1 5.00 Very Low Very Low Very Low
tolerance 1 5.00 Very Low Very Low Very Low
cva 1 5.00 Very Low Very Low Very Low
imagery 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Disease 9 70.28 Quite High
Multiple Myeloma 35 49.84 Quite Low
Constipation 3 49.32 Quite Low
Neuropathic Pain 3 48.64 Quite Low
Thrombosis 11 48.12 Quite Low
Exanthema 3 47.04 Quite Low
Cancer 6 44.28 Quite Low
Toxicity 6 25.60 Quite Low
Peripheral Neuropathy 6 5.00 Very Low Very Low Very Low
Recurrence 6 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
A retrospective study addressed specifically this issue; the total number of CD34 cells collected was not affected by previous duration or dose of thalidomide, or duration between thalidomide cessation and mobilization (Ghobrial et al 2003), while in another study the median number of CD34 was affected by the time from thalidomide discontinuation (Abdelkefi et al 2005).
Neg (not) Regulation (affected) of Negative_regulation (number) of CD34
1) Confidence 0.05 Published 2007 Journal Therapeutics and Clinical Risk Management Section Body Doc Link PMC2374936 Disease Relevance 0.07 Pain Relevance 0.35

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox